JPH0834720A - Skin external agent - Google Patents
Skin external agentInfo
- Publication number
- JPH0834720A JPH0834720A JP17501294A JP17501294A JPH0834720A JP H0834720 A JPH0834720 A JP H0834720A JP 17501294 A JP17501294 A JP 17501294A JP 17501294 A JP17501294 A JP 17501294A JP H0834720 A JPH0834720 A JP H0834720A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- group
- carbon atoms
- formula
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、皮膚外用剤に関し、詳
細には皮膚の保湿、肌荒れの予防・改善、角質正常化、
しわの予防・改善等に優れる皮膚外用剤、特に皮膚の老
化防止効果に優れた皮膚外用剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for skin, specifically, moisturizing skin, preventing / ameliorating rough skin, normalizing keratin,
The present invention relates to a skin external preparation that is excellent in preventing and improving wrinkles, and particularly relates to a skin external preparation that is excellent in the effect of preventing skin aging.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】近年、
健康で美しい肌を保つことが、老若男女を問わず、重大
な関心事となっている。ところが、肌は加齢、更に温
度、湿度、紫外線、化粧品、疾病、ストレス、食習慣等
により微妙な影響を受け、そのため、肌の諸機能(生体
からの水分等の損失を防ぎ、体温の恒常的維持を司どる
機能、外界からの物理的・化学的刺激及び種々の細菌か
らの身体保護機能、皮膚の弾力性を保持し、表面形態を
決定する機能等)の減退、肌の老化など、種々のトラブ
ルが発生する。2. Description of the Related Art In recent years,
Maintaining healthy and beautiful skin has become a serious concern for people of all ages. However, the skin is subtly affected by aging, temperature, humidity, ultraviolet rays, cosmetics, diseases, stress, eating habits, etc., and therefore various functions of the skin (prevention of loss of water etc. from the living body and constant body temperature). Function to control physical maintenance, physical and chemical stimulation from the outside world and body protection function from various bacteria, retention of elasticity of skin, function to determine surface morphology, etc.), skin aging, etc. Various troubles occur.
【0003】表皮における乾性、脂性肌、フケ症等の尋
常性の皮膚トラブルは、前記したように外環境の変化
(季節変化、紫外線等)や加齢や疾患に伴う生理機能の
変動といった生体に作用する体内外の因子による皮膚組
織の機能異常に加え、更にこれらにより誘起される皮膚
肥厚や不全角化等により発生する。[0003] As described above, dry skin, oily skin, and dermatitis vulgaris in the epidermis are caused by changes in the external environment (seasonal changes, ultraviolet rays, etc.) and physiological changes associated with aging and diseases. In addition to the functional abnormality of the skin tissue due to the acting factors inside and outside the body, it is caused by the skin thickening and parakeratosis induced by these.
【0004】このような皮膚トラブルを予防、改善する
主たる試みとしては、合成あるいは天然の保湿成分の塗
布により皮膚の乾燥を防ぎ皮膚の保湿能を高める方法、
血行促進剤の塗布により血行促進を改善する方法等がな
されてきた。The main attempts to prevent and improve such skin troubles are to apply a synthetic or natural moisturizing component to prevent the skin from drying and to increase the moisturizing ability of the skin.
A method of improving blood circulation promotion by applying a blood circulation promoter has been made.
【0005】一般に、肌にうるおいを与え、柔軟性を維
持するには、角質層中に含まれる水分が重要であること
が知られている。また、当該水分の保持には、角質層中
に含有される水溶性成分、すなわち、遊離アミノ酸、有
機酸、尿素又は無機イオン等が寄与していることも知ら
れており、従来、これらの水溶性成分を単独で又は組み
合わせて配合した薬用皮膚外用剤や化粧料が肌荒れの改
善又は予防の目的で使用されている。It is generally known that the water content in the stratum corneum is important in order to moisturize the skin and maintain flexibility. Further, it is also known that a water-soluble component contained in the stratum corneum, that is, a free amino acid, an organic acid, urea, an inorganic ion, or the like contributes to the retention of the water, and conventionally, these water-soluble components are used. BACKGROUND ART External medicated skin preparations and cosmetics in which sex components are mixed alone or in combination are used for the purpose of improving or preventing rough skin.
【0006】また、これらの角質層中に含まれる水溶性
成分とは別に、水との親和性の高い様々な保湿性物質が
開発されており、同様の目的で使用されている。In addition to the water-soluble components contained in the stratum corneum, various moisturizing substances having high affinity with water have been developed and used for the same purpose.
【0007】しかしながら、従来の水溶性成分や保湿性
物質を皮膚に適用した場合、その作用は皮膚角質上にあ
って水分を角質に供給するというもので、その効果は一
時的であり、根本的に角質層の水分保持能力を改善し、
肌荒れを本質的に予防又は治癒させるというものではな
かった。[0007] However, when a conventional water-soluble component or moisturizing substance is applied to the skin, its effect is that it exists on the skin keratin and supplies water to the keratin, and its effect is temporary and fundamental. To improve the water retention capacity of the stratum corneum,
It did not essentially prevent or heal skin irritation.
【0008】一方、皮膚のトラブルの一つであるしわ
は、加齢、乾燥、紫外線等による老化により発生する。
すなわち、乾燥、紫外線等の外界からの物理的・化学的
刺激による表皮の表面形態の変化及び加齢、疾病、スト
レス等による真皮での組織の変性、特にコラーゲン繊維
が大きく失われ真皮の退化、皮下脂肪組織の減少などに
より、皮膚が老化し、これが主にしわ弛緩及び弾力性損
失の原因となる。On the other hand, wrinkles, which are one of the skin troubles, are caused by aging due to aging, drying, ultraviolet rays and the like.
That is, dryness, changes in the surface morphology of the epidermis due to physical and chemical stimuli from the outside such as ultraviolet rays and aging, diseases, degeneration of tissues in the dermis due to stress, etc. Aging of the skin, such as loss of subcutaneous adipose tissue, is the main cause of wrinkle relaxation and loss of elasticity.
【0009】従来、このような老化作用によるしわを抑
制したり、治療したりするために、種々の組成物や方法
が提案されている(特開昭62−185005号公報、
特開昭62−502546号公報、特開平2−7215
7号公報、特開平2−288822号公報等)。Conventionally, various compositions and methods have been proposed in order to suppress or treat such wrinkles due to aging (Japanese Patent Laid-Open No. 185005/1987).
JP-A-62-502546, JP-A-2-7215
No. 7, JP-A-2-288822, etc.).
【0010】しかし、これらはいずれも、満足のいくし
わ改善効果を奏するものではなかった。However, none of them has shown a satisfactory wrinkle improving effect.
【0011】従って、本発明の目的は、角質層の水分保
持能力を根本的に改善し、皮膚の正常な機能を回復、更
にしわを効果的に予防・改善することにより皮膚の老化
を防止する皮膚外用剤を提供することにある。Therefore, the object of the present invention is to fundamentally improve the water-retaining ability of the stratum corneum, restore the normal function of the skin, and effectively prevent and improve wrinkles to prevent skin aging. It is to provide a skin external preparation.
【0012】[0012]
【課題を解決するための手段】そこで、本出願人は角質
層の水分保持能力を根本的に改善する化合物を求めるべ
く検討してきたところ、下記の一般式(2′)Therefore, the applicant of the present invention has investigated to obtain a compound that fundamentally improves the water-retaining ability of the stratum corneum. The following general formula (2 ')
【0013】[0013]
【化3】 Embedded image
【0014】〔式中、R9は炭素数10〜26の直鎖又
は分岐鎖の飽和又は不飽和の炭化水素基を示し、R10は
炭素数9〜25の直鎖又は分岐鎖の飽和又は不飽和の炭
化水素基を示す〕で表されるアミド誘導体を保湿剤とし
て用いれば角質層の水分保持能力を改善できることを見
出し、先に出願した(特許第1557842号)。[0014] wherein, R 9 represents a linear or branched, saturated or unsaturated hydrocarbon group of 10-26 carbon atoms, R 10 is a saturated or a straight-chain or branched-chain 9 to 25 carbon atoms It was found that the water retention ability of the stratum corneum can be improved by using an amide derivative represented by [Unsaturated hydrocarbon group] as a moisturizing agent, and filed previously (Patent No. 1557842).
【0015】しかし、前述の如く近年更なる効果の向上
が望まれており、本発明者らは種々の化合物について検
討を行ったところ、後記一般式(1)で表わされるアミ
ン誘導体又はその酸付加塩と後記一般式(2)で表わさ
れるアミド誘導体とを組み合わせて用いれば、更に角質
層の水分保持能力を向上し、極めて優れた肌荒れの予防
及び改善効果を有し、更に皮膚の不全角化、表皮肥厚、
脂質代謝異常等に対し、顕著な抑制効果を有し、しわの
発生を抑制し、かつ消滅せしめるという皮膚老化防止効
果に優れた皮膚外用剤が得られることを見出し、本発明
を完成した。However, as described above, further improvement of the effect is desired in recent years, and the present inventors have studied various compounds. As a result, the amine derivative represented by the following general formula (1) or its acid addition is shown. When a salt and an amide derivative represented by the general formula (2) described below are used in combination, the water-retaining ability of the stratum corneum is further improved, and it has an extremely excellent effect of preventing and improving rough skin, and further hyperkeratosis of the skin. , Epidermal thickening,
The present invention has been completed by discovering that a skin external preparation having a remarkable inhibitory effect on lipid metabolism abnormality and the like, which suppresses the generation of wrinkles and has an excellent anti-aging effect on skin, can be obtained.
【0016】すなわち、本発明は次の成分(A)及び
(B): (A)次の一般式(1)That is, the present invention has the following components (A) and (B): (A) The following general formula (1)
【0017】[0017]
【化4】 [Chemical 4]
【0018】(式中、R1は炭素数1〜3の炭化水素基
又は炭素数1〜5のヘテロ原子を含有する炭化水素基を
示し、R2、R3、R4、R5及びR6は、同一又は異なっ
て、水素原子又は炭素数1〜20の水酸基が置換してい
てもよい炭化水素基を示す)で表されるアミン誘導体又
はその酸付化塩から選ばれる一種又は二種以上、 (B)次の一般式(2)(In the formula, R 1 represents a hydrocarbon group having 1 to 3 carbon atoms or a hydrocarbon group having 1 to 5 carbon atoms and containing a hetero atom, and R 2 , R 3 , R 4 , R 5 and R 5 6 is the same or different and represents a hydrogen atom or a hydrocarbon group which may be substituted with a hydroxyl group having 1 to 20 carbon atoms), or one or two kinds selected from an amine derivative or an acidified salt thereof. Above, (B) the following general formula (2)
【0019】[0019]
【化5】 Embedded image
【0020】〔式中、R7は炭素数10〜26の直鎖又
は分岐鎖の飽和又は不飽和の炭化水素基を示し、R8は
炭素数9〜25の直鎖又は分岐鎖の飽和又は不飽和の炭
化水素基を示し、Y及びZはそれぞれ水素原子又は−
(CH2)n−OH(ここでnは1〜3の数を示す)を示
し、Aは単結合又は−O−CH2−(但し、酸素原子は
R7と結合する)を示す〕で表されるアミド誘導体から
選ばれる一種又は二種以上を含有することを特徴とする
皮膚外用剤を提供するものである。[In the formula, R 7 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms, and R 8 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms. Represents an unsaturated hydrocarbon group, and Y and Z are each a hydrogen atom or-
In showing the (where the oxygen atom binds to R 7)] - (CH 2) n -OH (where n is a number of 1 to 3) indicates, A represents a single bond or -O-CH 2 It is intended to provide a skin external preparation characterized by containing one or more selected from the amide derivatives represented.
【0021】なお、本発明に使用されるアミン誘導体
(1)の一部は公知のものである(例えばルーマニア国
特許68−58619号公報)。しかし、それら公知の
化合物の皮膚に対する作用、特にしわ改善及び角化改善
に関する作用については全く知られていない。A part of the amine derivative (1) used in the present invention is publicly known (for example, Romanian Patent 68-58619). However, nothing is known about the effects of these known compounds on the skin, especially the effects on wrinkle improvement and keratinization improvement.
【0022】本発明に用いられる(A)成分である一般
式(1)で表わされるアミン誘導体において、一般式
(1)中、R1〜R6の炭化水素基としては、飽和又は不
飽和の直鎖、分岐鎖又は環状のいずれでもよい。R1の
炭素数1〜3の炭化水素基としては炭素数1〜3のアル
キル又はアルケニル基が挙げられ、具体例としては、メ
チル、エチル、プロピル、イソプロピル、アリル等が挙
げられる。R1の炭素数1〜5のヘテロ原子を含有する
炭化水素基としては、酸素原子、窒素原子、ケイ素原
子、硫黄原子、リン原子、フッ素原子を有する炭化水素
基が挙げられる。酸素原子及び/又は窒素原子を含む炭
化水素基の具体例としては、2−ヒドロキシエチル、3
−ヒドロキシプロピル、2,3−ジヒドロキシプロピ
ル、2,2−ビス(ヒドロキシメチル)−3−ヒドロキ
シプロピル、カルボキシメチル、アミノカルボニルメチ
ル、1−(N,N−ジメチルアミノ)エチル等が挙げら
れる。このうち、1〜3個の水酸基が置換した炭素数1
〜5のアルキル基が特に好ましい。In the amine derivative represented by the general formula (1) which is the component (A) used in the present invention, the hydrocarbon group represented by R 1 to R 6 in the general formula (1) is saturated or unsaturated. It may be linear, branched or cyclic. Examples of the hydrocarbon group having 1 to 3 carbon atoms of R 1 include alkyl or alkenyl groups having 1 to 3 carbon atoms, and specific examples thereof include methyl, ethyl, propyl, isopropyl, allyl and the like. Examples of the hydrocarbon group containing a hetero atom having 1 to 5 carbon atoms of R 1 include a hydrocarbon group having an oxygen atom, a nitrogen atom, a silicon atom, a sulfur atom, a phosphorus atom and a fluorine atom. Specific examples of the hydrocarbon group containing an oxygen atom and / or a nitrogen atom include 2-hydroxyethyl and 3
-Hydroxypropyl, 2,3-dihydroxypropyl, 2,2-bis (hydroxymethyl) -3-hydroxypropyl, carboxymethyl, aminocarbonylmethyl, 1- (N, N-dimethylamino) ethyl and the like can be mentioned. Among these, 1 to 3 carbon atoms substituted with 1 to 3 hydroxyl groups
Particularly preferred are alkyl groups of -5.
【0023】一般式(1)中、R2、R3、R4、R5及び
R6としては水素原子及び1〜5個の水酸基が置換して
いてもよい炭素数1〜20、好ましくは1〜5の炭化水
素基が挙げられ、このうち、好ましい具体例としては、
水素原子;メチル、エチル、ブチル、ヘキシル、テトラ
デシル、オクタデシル等の炭素数1〜20のアルキル
基;フェニル等のアリール基;ベンジル等のアラルキル
基;ヒドロキシメチル、2−ヒドロキシエチル、1,2
−ジヒドロキシプロピル、1,2,3−トリヒドロキシ
ブチル、1,2,3,4−テトラヒドロキシペンチル、
1,2,3,4,5−ペンタヒドロキシヘキシル等の1
〜5個の水酸基が置換したアルキル基が挙げられる。In the general formula (1), R 2 , R 3 , R 4 , R 5 and R 6 each have a hydrogen atom and 1 to 5 carbon atoms which may be substituted by 1 to 5 hydroxyl groups, preferably 1 to 20 carbon atoms. 1 to 5 hydrocarbon groups are mentioned, and among them, preferable specific examples include:
Hydrogen atom; alkyl group having 1 to 20 carbon atoms such as methyl, ethyl, butyl, hexyl, tetradecyl, octadecyl; aryl group such as phenyl; aralkyl group such as benzyl; hydroxymethyl, 2-hydroxyethyl, 1,2
-Dihydroxypropyl, 1,2,3-trihydroxybutyl, 1,2,3,4-tetrahydroxypentyl,
1,2,3,4,5-pentahydroxyhexyl etc. 1
Examples thereof include an alkyl group in which 5 hydroxyl groups are substituted.
【0024】アミン誘導体(1)としては、R1が炭素
数1〜3のアルキル基又は1〜3個の水酸基が置換した
炭素数1〜5のアルキル基であり、R2が水素原子、2
−ヒドロキシエチル基、メチル基又はベンジル基であ
り、R3、R4、R5、R6が水素原子、メチル基、ヒドロ
キシメチル基、2−ヒドロキシエチル基又は1,2,
3,4−テトラヒドロキシペンチル基である化合物が特
に好ましい。In the amine derivative (1), R 1 is an alkyl group having 1 to 3 carbon atoms or an alkyl group having 1 to 5 carbon atoms substituted with 1 to 3 hydroxyl groups, and R 2 is a hydrogen atom, 2
A hydroxyethyl group, a methyl group or a benzyl group, wherein R 3 , R 4 , R 5 and R 6 are a hydrogen atom, a methyl group, a hydroxymethyl group, a 2-hydroxyethyl group or 1,2,
A compound which is a 3,4-tetrahydroxypentyl group is particularly preferred.
【0025】本発明に使用される一般式(1)で表わさ
れるアミン誘導体は、公知の種々の方法により合成され
る。例えば、下記反応式で表わされるように、グリシジ
ルエーテル誘導体(3)にアミン誘導体(4)を付加さ
せることにより合成される。The amine derivative represented by the general formula (1) used in the present invention is synthesized by various known methods. For example, as represented by the following reaction formula, it is synthesized by adding an amine derivative (4) to a glycidyl ether derivative (3).
【0026】[0026]
【化6】 [Chemical 6]
【0027】(式中、R1、R2、R3、R4、R5及びR6
はそれぞれ前記と同じ意味を有する)(Wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6
Each has the same meaning as above)
【0028】また、本発明に使用されるアミン誘導体
(1)の酸付加塩としては、塩酸、硫酸、硝酸、リン酸
等の無機酸塩、又はコハク酸、フマル酸、ヘキサデカン
酸、オクタデカン酸、乳酸、グリコール酸、クエン酸、
酒石酸、安息香酸等の有機酸塩などが挙げられる。これ
らは、常法により、アミン誘導体(1)と上記それぞれ
の酸とを反応させることにより得られる。As the acid addition salt of the amine derivative (1) used in the present invention, inorganic acid salts such as hydrochloric acid, sulfuric acid, nitric acid and phosphoric acid, or succinic acid, fumaric acid, hexadecanoic acid, octadecanoic acid, Lactic acid, glycolic acid, citric acid,
Examples thereof include organic acid salts such as tartaric acid and benzoic acid. These are obtained by reacting the amine derivative (1) with each of the above acids by a conventional method.
【0029】本発明において(A)成分のアミン誘導体
及びその酸付加塩は一種を単独で、又は二種以上を組み
合わせて用いることができ、その配合量は特に制限され
ないが、全組成中に0.0001〜5重量%(以下、単
に%で示す)、特に0.0001〜1%、更に0.00
01〜0.1%が好ましい。また、スクワラン等の液状
炭化水素を基剤とする油性の皮膚外用剤とする場合、
(A)成分の配合量は全組成中0.0001〜10%、
特に0.0001〜5%、更に0.0001〜2%とす
ることが好ましい。In the present invention, the amine derivative as the component (A) and the acid addition salt thereof can be used alone or in combination of two or more, and the compounding amount is not particularly limited, but it is 0 in the whole composition. 0.0001 to 5% by weight (hereinafter referred to simply as%), particularly 0.0001 to 1%, and further 0.00
01-0.1% is preferable. In addition, when using an oily external preparation for skin based on liquid hydrocarbon such as squalane,
The blending amount of the component (A) is 0.0001 to 10% in the entire composition,
In particular, it is preferably 0.0001 to 5%, more preferably 0.0001 to 2%.
【0030】また、本発明に用いられる(B)成分であ
る一般式(2)で表わされるアミド誘導体において、一
般式(2)中、R7は炭素数10〜26の直鎖又は分岐
鎖の飽和又は不飽和の炭化水素基を示すが、その具体例
としては、デシル基、ウンデシル基、ドデシル基、トリ
デシル基、テトラデシル基、ペンタデシル基、ヘキサデ
シル基、オクタデシル基、エイコシル基、ドコシル基、
テトラコシル基、ペンタコシル基、ヘキサコシル基、2
−エチルオクチル基、3−エチルオクチル基等のアルキ
ル基;オレイル基、リノレイル基等のアルケニル基;ア
ントラセニル基等の脂環式炭化水素基;ジフェニルメチ
ル基、ナフチル基等の芳香族炭化水素基が挙げられる。
また、一般式(2)中、R8は炭素数9〜25の直鎖又
は分岐鎖の飽和又は不飽和の炭化水素基を示すが、その
具体例としては、ノニル基、2−メチルオクチル基等の
アルキル基;メシチル基等の芳香族炭化水素基;及び前
記の炭化水素基のうち、炭素数25までのものが挙げら
れる。In the amide derivative represented by the general formula (2) which is the component (B) used in the present invention, in the general formula (2), R 7 is a linear or branched chain having 10 to 26 carbon atoms. A saturated or unsaturated hydrocarbon group is shown, and specific examples thereof include decyl group, undecyl group, dodecyl group, tridecyl group, tetradecyl group, pentadecyl group, hexadecyl group, octadecyl group, eicosyl group, docosyl group,
Tetracosyl group, pentacosyl group, hexacosyl group, 2
-Alkyl groups such as ethyloctyl group and 3-ethyloctyl group; alkenyl groups such as oleyl group and linoleyl group; alicyclic hydrocarbon groups such as anthracenyl group; aromatic hydrocarbon groups such as diphenylmethyl group and naphthyl group. Can be mentioned.
Further, in the general formula (2), R 8 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms, and specific examples thereof include a nonyl group and a 2-methyloctyl group. And other alkyl groups; aromatic hydrocarbon groups such as mesityl groups; and the above hydrocarbon groups having up to 25 carbon atoms.
【0031】かかるアミド誘導体(2)は、公知の方法
〔例えば、ポリッシュ・ジャーナル・オブ・ケミストリ
ー(Pol.J.Chem.)52,1059(197
8);同52,1283(1978);特開昭54−1
17421号、同54−144308号、同54−14
7937号公報〕に準じて製造することができる。すな
わち、次に示される反応式に従って、グリシジルエーテ
ル(5)とアルカノールアミン(6)から得られる化合
物(7)をアシル化し、次いでエステル基を選択的に加
水分解することによって製造することができる。The amide derivative (2) is prepared by a known method [for example, Polish Journal of Chemistry (Pol. J. Chem.) 52 , 1059 (197).
8); ibid. 52 , 1283 (1978); JP-A-54-1.
No. 17421, No. 54-144308, No. 54-14
7937 gazette]. That is, it can be produced by acylating the compound (7) obtained from the glycidyl ether (5) and the alkanolamine (6) according to the reaction formula shown below, and then selectively hydrolyzing the ester group.
【0032】[0032]
【化7】 [Chemical 7]
【0033】〔式中、R7、R8、Y及びZは前記と同じ
意味を有し、Z′はZが−(CH2)n−OHの場合はZ
から水素原子を除いたアニオン基を示し、Zが水素原子
の場合は単結合を示す〕[Wherein R 7 , R 8 , Y and Z have the same meanings as described above, and Z ′ is Z when Z is — (CH 2 ) n —OH.
Represents an anion group excluding a hydrogen atom, and represents a single bond when Z is a hydrogen atom.]
【0034】かかるアミド誘導体のうち特に好ましいも
のとしては次の一般式(2−a)及び一般式(2−b)
で表わされるものである。Among these amide derivatives, particularly preferred are the following general formulas (2-a) and (2-b).
Is represented by.
【0035】[0035]
【化8】 Embedded image
【0036】〔式中、R7及びR8は前記と同じ意味を有
する〕[In the formula, R 7 and R 8 have the same meaning as described above]
【0037】本発明において(B)成分のアミド誘導体
は一種を単独で、又は二種以上を組み合わせて用いるこ
とができ、その配合量は特に制限されないが、全組成中
に0.001〜50%、特に0.1〜20%が好まし
い。In the present invention, the amide derivative as the component (B) can be used alone or in combination of two or more kinds, and the compounding amount is not particularly limited, but 0.001 to 50% in the total composition. , Particularly preferably 0.1 to 20%.
【0038】本発明の皮膚外用剤はその使用形態によ
り、薬用皮膚外用剤と化粧料に大別される。The external preparation for skin of the present invention is roughly classified into a medicated external preparation for skin and cosmetics depending on its use form.
【0039】薬用皮膚外用剤としては、例えば薬効成分
を含有する各種軟膏剤を挙げることができる。ここで、
軟膏剤としては、油性基剤をベースとするもの、油/水
(O/W)、水/油(W/O)型の乳化系基剤をベース
とするもののいずれであってもよい。また、油性基剤と
しては、特に制限はなく、例えば植物油、動物油、合成
油、脂肪酸及び天然又は合成のグリセライド等が挙げら
れる。更に、薬効成分としては、特に制限はなく、例え
ば鎮痛消炎剤、鎮痒剤、殺菌消毒剤、収斂剤、皮膚軟化
剤、ホルモン剤等を必要に応じて適宜使用することがで
きる。Examples of the external medicated skin preparation include various ointments containing medicinal components. here,
The ointment may be either an oil-based base, an oil / water (O / W) or water / oil (W / O) type emulsion base. The oily base is not particularly limited, and examples thereof include vegetable oil, animal oil, synthetic oil, fatty acid and natural or synthetic glyceride. Further, the medicinal component is not particularly limited, and for example, an analgesic / anti-inflammatory agent, an antipruritic agent, a bactericidal disinfectant, an astringent agent, an emollient agent, a hormone agent and the like can be appropriately used as necessary.
【0040】また、化粧料としては、種々の形態、例え
ばW/O、O/W型乳化化粧料、クリーム、化粧乳液、
化粧水、油性化粧料、パック剤、口紅、ファウンデーシ
ョン、皮膚洗浄剤、ヘアートニック、整髪剤、養毛剤、
育毛剤等の皮膚化粧料とすることができる。As the cosmetics, various forms such as W / O, O / W type emulsified cosmetics, creams, cosmetic emulsions,
Lotion, oily cosmetic, pack, lipstick, foundation, skin cleanser, hair tonic, hair styling agent, hair nourishing agent,
It can be a skin cosmetic such as a hair restorer.
【0041】本発明の皮膚外用剤を化粧料として使用す
る場合、必須成分の他に化粧料成分として一般に使用さ
れている油分、保湿剤、紫外線吸収剤、アルコール類、
キレート剤、pH調整剤、防腐剤、増粘剤、色素、香料等
を任意に組み合わせて配合することができる。When the external preparation for skin of the present invention is used as a cosmetic, in addition to the essential ingredients, oils, moisturizers, UV absorbers, alcohols, which are generally used as cosmetic ingredients,
A chelating agent, a pH adjuster, an antiseptic, a thickener, a dye, a fragrance and the like can be optionally combined and blended.
【0042】本発明の皮膚外用剤は、上述の必須成分で
ある(A)成分及び(B)成分並びに他の油相成分を加
温して溶解したものに、必要に応じて水相成分を加えて
混合することにより製造するのが好ましい。The external preparation for skin of the present invention is obtained by heating and dissolving the above-mentioned essential components (A) and (B) and other oil phase components, and if necessary, an aqueous phase component. In addition, it is preferable to manufacture by mixing.
【0043】[0043]
【発明の効果】本発明の皮膚外用剤は、(A)成分のア
ミン誘導体又はその酸付加塩と(B)成分のアミド誘導
体とを併用することにより、相乗的な角質水分保持能力
の向上効果を奏し、紫外線その他種々の因子の影響によ
る不全角化、表皮肥厚、脂質代謝異常などに対し顕著な
抑制作用を有し、しかも皮膚の正常な機能を回復させ、
更にしわの発生を顕著に抑制し、またしわを消滅させる
効果に優れ、皮膚の老化を防止することができる。INDUSTRIAL APPLICABILITY The external preparation for skin of the present invention uses the amine derivative or its acid addition salt of the component (A) in combination with the amide derivative of the component (B) to synergistically improve the keratin water retention ability. It has a remarkable inhibitory effect on parakeratosis due to the influence of ultraviolet rays and various other factors, epidermal thickening, lipid metabolism abnormality, and restores the normal function of the skin,
Furthermore, the generation of wrinkles is significantly suppressed, and the effects of eliminating wrinkles are excellent, and skin aging can be prevented.
【0044】[0044]
【実施例】以下に実施例を挙げて本発明を具体的に説明
するが、本発明はこれらによって何ら限定されるもので
はない。尚、本実施例における肌荒れ改善効果、角質改
善効果及びしわ改善効果についての評価方法を以下に示
す。EXAMPLES The present invention will be described in detail below with reference to examples, but the present invention is not limited thereto. The evaluation methods for the rough skin improving effect, the keratin improving effect and the wrinkle improving effect in this example are shown below.
【0045】<評価方法> 肌荒れ改善効果:冬期に頬部に肌荒れを起こしている2
0〜50才の女性10名を被験者とし、左右の頬に異な
る被験皮膚外用剤を2週間塗布する。2週間の塗布が終
了した翌日に、次の項目につき試験を行った。 (1)皮膚コンダクタンス 37℃の温水にて洗顔後、温度20℃、湿度40%の部
屋で20分間安静にした後、角質層の水分含有量を皮膚
コンダクタンスメーター(IBS社製)にて測定した。
皮膚コンダクタンス値は値が小さいほど肌荒れが生じて
いて、5以下ではひどい肌荒れが生じていることを示
す。一方、皮膚コンダクタンス値が20以上であれば、
肌荒れはほとんど生じていない。 (2)肌荒れスコア 肌荒れを肉眼で観察し、下記に示す基準により判定し
た。スコアは平均値±標準偏差で示した。<Evaluation method> Rough skin improving effect: Rough skin on cheeks in winter 2
Ten women aged 0 to 50 are used as subjects, and different test skin external preparations are applied to the left and right cheeks for 2 weeks. On the day after the application for two weeks was completed, the following items were tested. (1) Skin conductance After washing the face with warm water of 37 ° C. and resting in a room at a temperature of 20 ° C. and a humidity of 40% for 20 minutes, the water content of the stratum corneum was measured with a skin conductance meter (manufactured by IBS). .
The skin conductance value indicates that the smaller the value, the rougher the skin is, and if the value is 5 or less, the rougher the skin is. On the other hand, if the skin conductance value is 20 or more,
Almost no rough skin has occurred. (2) Rough skin score Rough skin was visually observed and judged according to the following criteria. The score was shown by the average value +/- standard deviation.
【0046】0:肌荒れを認めない。 1:かすかに肌荒れを認める。 2:肌荒れを認める。 3:ややひどい肌荒れを認める。 4:ひどい肌荒れを認める。0: No rough skin is observed. 1: Slightly rough skin is recognized. 2: Rough skin is recognized. 3: Slightly rough skin is recognized. 4: Severe rough skin is recognized.
【0047】角質改善効果:蛍光色素のダンシルクロラ
イドを白色ワセリン中に5重量%配合した軟膏を作り、
被験者の前腕部の皮膚に24時間閉塞貼布し、角質層に
ダンシルクロライドを浸透結合させる。その後同じ部位
に1日2回(朝・夕)被験皮膚外用剤を塗布し、毎日ダ
ンシルクロライドの蛍光をしらべ、その蛍光が消滅する
までの日数を皮膚角質層のターンオーバー速度とした。
なお、通常の皮膚角質層のターンオーバー速度は14〜
16日であるが、老化した皮膚においては18日前後に
のびる。それに対して老化防止効果が現れると12日前
後にまで短縮される。 しわ改善効果:ヘアレスマウス(HR/ICR,実験開
始時9週齢)に、東芝健康線用ランプ20SEを6本使
用してUVB光を週3回照射した。エネルギー量はTO
KYOOPTICAL社製のUV−Radiomete
r UVR−305/365Dを用いて測定した。1回
の照射量は1MED以下とし、0.28mW/cm2のエネ
ルギー量で65mJとした。照射期間は20週間で、ヘア
レスマウス背部にしわが形成されていることを確認した
後、8匹ずつの群に分け、被験皮膚外用剤を週5回、6
週間塗布した。塗布終了後、しわの度合いを肉眼によ
り、下記の基準(しわ指数)で評価した。Keratin improvement effect: An ointment was prepared by adding 5% by weight of the fluorescent dye dansyl chloride to white petrolatum,
The skin of the forearm of the subject is occluded and applied to the skin for 24 hours, and dansyl chloride is osmotically bonded to the stratum corneum. After that, the test skin external preparation was applied to the same site twice a day (morning and evening), and the fluorescence of dansyl chloride was examined every day. The number of days until the fluorescence disappeared was defined as the turnover rate of the stratum corneum of the skin.
The normal turnover speed of the stratum corneum is 14-
Although it is 16 days, it spreads around 18 days in aged skin. On the other hand, when the anti-aging effect appears, it is shortened to around 12 days. Wrinkle improvement effect: Hairless mice (HR / ICR, 9 weeks old at the start of the experiment) were irradiated with UVB light three times a week using six Toshiba Health Line lamps 20SE. Energy amount is TO
UV-Radiomate made by KYOOPTICAL
r UVR-305 / 365D. The irradiation amount per irradiation was 1 MED or less, and the energy amount was 0.28 mW / cm 2 and was 65 mJ. The irradiation period was 20 weeks, and after confirming that wrinkles were formed on the back of the hairless mouse, they were divided into groups of 8 mice each, and the test external preparation was administered 5 times a week for 6 times.
It was applied for a week. After the application, the degree of wrinkles was evaluated with the naked eye according to the following criteria (wrinkle index).
【0048】(しわ指数評価基準) 1:しわが完全に消滅。 2:しわがあるのかないのかわからない。 3:しわが少しある。 4:しわが非常にある。(Wrinkle index evaluation standard) 1: Wrinkles disappear completely. 2: I don't know if there are wrinkles or not. 3: There are some wrinkles. 4: Very wrinkled.
【0049】実施例1 表1に示す組成のW/O型クリームを下記製法により調
整し、それぞれについて連続塗布による肌荒れ改善効果
の評価を行った。使用したアミン誘導体の構造と配合量
を表2に示し、アミド誘導体の構造と配合量を表3に示
し、肌荒れ改善効果の評価結果を表4に示す。Example 1 W / O type creams having the compositions shown in Table 1 were prepared by the following production method, and the effect of improving rough skin by continuous application was evaluated for each. The structure and blending amount of the amine derivative used are shown in Table 2, the structure and blending amount of the amide derivative are shown in Table 3, and the evaluation results of the rough skin improving effect are shown in Table 4.
【0050】[0050]
【表1】 (組成) (%) (1)アミン誘導体 表2 (2)アミド誘導体 表3 (3)コレステロール 0.5 (4)コレステリルイソステアレート 1.0 (5)ポリエーテル変性シリコーン*1 1.5 (6)環状シリコーン*2 20.0 (7)メチルフェニポリシロキサン*3 2.0 (8)メチルポリシロキサン*4 2.0 (9)硫酸マグネシウム 0.5 (10)55%エタノール 5.0 (11)精製水 残量 (12)防腐剤 適量 (13)香料 適量[Table 1] (Composition) (%) (1) Amine derivative Table 2 (2) Amide derivative Table 3 (3) Cholesterol 0.5 (4) Cholesteryl isostearate 1.0 (5) Polyether-modified silicone * 1 1.5 (6) Cyclic silicone * 2 20.0 (7) Methylphenipolysiloxane * 3 2.0 (8) Methylpolysiloxane * 4 2.0 (9) Magnesium sulfate 0.5 (10) 55% ethanol 5.0 (11) Purified water Remaining amount (12) Preservative Suitable amount (13) Perfume Suitable amount
【0051】*1:シリコーンKF−6015,信越化
学工業(株)製 *2:シリコーンSH−244、SH−245又はSH
−244とSH−245の3:2(重量比)混合物,東
レダウコーニング・シリコーン(株)製 *3:シリコーンSF−557,東レダウコーニング・
シリコーン(株)製 *4:シリコーンKF−96A(6cs) ,信越化学工業
(株)製* 1: Silicone KF-6015, manufactured by Shin-Etsu Chemical Co., Ltd. * 2: Silicone SH-244, SH-245 or SH
-244 and SH-245 3: 2 (weight ratio) mixture, manufactured by Toray Dow Corning Silicone Co., Ltd. * 3: Silicone SF-557, Toray Dow Corning
Silicone Co., Ltd. * 4: Silicone KF-96A (6cs), Shin-Etsu Chemical Co., Ltd.
【0052】(製法)油相成分〔(1)〜(5)、
(7)、(8)〕を80℃で加熱溶解したものに、攪拌
しながら80℃に加熱した水相成分〔(9)、(1
1)、(12)〕を加えて乳化した後、50℃まで攪拌
冷却後、(6)、(10)、(13)を加え、更に攪拌
しながら室温まで冷却し、W/O型クリームを調製し
た。(Production method) Oil phase component [(1) to (5),
(7), (8)] heated and dissolved at 80 ° C., and an aqueous phase component [(9), (1
1) and (12)] are added and emulsified, and after stirring and cooling to 50 ° C., (6), (10) and (13) are added, and the mixture is further cooled to room temperature with stirring to give a W / O type cream. Prepared.
【0053】[0053]
【表2】 [Table 2]
【0054】[0054]
【表3】 [Table 3]
【0055】[0055]
【表4】 [Table 4]
【0056】表4の結果から、明らかなように、本発明
のW/O型クリームは、いずれもこれを皮膚に塗布する
ことにより顕著な肌荒れ改善効果が認められた。As is clear from the results shown in Table 4, all of the W / O type creams of the present invention exhibited a remarkable effect of improving rough skin by applying the cream to the skin.
【0057】実施例2 表5に示す組成のO/W型クリームを下記製法により調
製し、それぞれについて連続塗布による角質改善効果を
評価した。使用したアミン誘導体及びアミド誘導体の構
造と配合量は、実施例1で用いたそれぞれ表2、3に示
したものを用いた。角質改善効果の評価結果を表6に示
す。Example 2 O / W creams having the compositions shown in Table 5 were prepared by the following production method, and the effect of improving keratin by continuous application was evaluated for each of them. The structures and blending amounts of the amine derivative and the amide derivative used were those shown in Tables 2 and 3 used in Example 1, respectively. Table 6 shows the evaluation results of the effect of improving keratin.
【0058】[0058]
【表5】 (組成) (%) (1)ポリオキシエチレン(10)硬化ヒマシ油 1.0 (2)モノステアリン酸ソルビタン 0.5 (3)ステアロイルメチルタウリンナトリウム 0.5 (4)セトステアリルアルコール 2.0 (5)ステアリン酸 1.8 (6)アミン誘導体 表2 (7)アミド誘導体 表3 (8)コレステロール 1.5 (9)コレステリルイソステアレート 1.0 (10)ジカプリン酸ネオペンチルグリコール 8.0 (11)メチルポリシロキサン*5 5.0 (12)グリセリン 5.0 (13)1,3−ブチレングリコール 3.0 (14)防腐剤 適量 (15)精製水 残量 (16)香料 適量 *5:シリコーンKF−96A(6cs) 、信越化学工業(株)製[Table 5] (Composition) (%) (1) Polyoxyethylene (10) hydrogenated castor oil 1.0 (2) sorbitan monostearate 0.5 (3) sodium stearoylmethyl taurine 0.5 (4) cetostearyl Alcohol 2.0 (5) Stearic acid 1.8 (6) Amine derivative Table 2 (7) Amide derivative Table 3 (8) Cholesterol 1.5 (9) Cholesteryl isostearate 1.0 (10) Neopentyl dicaprate Glycol 8.0 (11) Methylpolysiloxane * 5 5.0 (12) Glycerin 5.0 (13) 1,3-Butylene glycol 3.0 (14) Preservative proper amount (15) Purified water balance (16) Fragrance suitable amount * 5: Silicone KF-96A (6cs), manufactured by Shin-Etsu Chemical Co., Ltd.
【0059】(製法)油相成分〔(1)〜(11)〕を
80℃で加熱溶解したものに、攪拌しながら80℃に加
熱した水相成分〔(12)〜(15)〕を加えて乳化し
た後、50℃まで攪拌冷却し、次いで(16)を加え、
更に攪拌しながら室温まで冷却し、O/W型クリームを
調整した。(Manufacturing method) To an oil phase component [(1) to (11)] heated and dissolved at 80 ° C, an aqueous phase component [(12) to (15)] heated to 80 ° C with stirring was added. After emulsifying, stir and cool to 50 ° C, then add (16),
The mixture was further cooled to room temperature with stirring to prepare an O / W type cream.
【0060】[0060]
【表6】 [Table 6]
【0061】表6の結果から明らかなように、本発明品
を皮膚に塗布することにより、角質を有効に改善するこ
とが認められた。As is clear from the results in Table 6, it was confirmed that the keratin was effectively improved by applying the product of the present invention to the skin.
【0062】実施例3 表7に示す組成の軟膏を常法により調製し、それぞれに
ついてのしわ改善効果を評価した。使用したアミン誘導
体及びアミド誘導体の構造と配合量は、実施例1で用い
たそれぞれ表2、3に示したものを用いた。しわ改善効
果の評価結果を表8に示す。Example 3 An ointment having the composition shown in Table 7 was prepared by a conventional method, and the wrinkle improving effect of each was evaluated. The structures and blending amounts of the amine derivative and the amide derivative used were those shown in Tables 2 and 3 used in Example 1, respectively. Table 8 shows the evaluation results of the wrinkle improving effect.
【0063】[0063]
【表7】 (組成) (%) (1)アミン誘導体 表2 (2)アミド誘導体 表3 (3)白色ワセリン 残量 (4)コレステリルイソステアレート 3.0 (5)流動パラフィン 10.0 (6)グリセリルエーテル*6 1.0 (7)グリセリン 10.0[Table 7] (Composition) (%) (1) Amine derivative Table 2 (2) Amide derivative Table 3 (3) White petrolatum residual amount (4) Cholesteryl isostearate 3.0 (5) Liquid paraffin 10.0 ( 6) Glyceryl ether * 6 1.0 (7) Glycerin 10.0
【0064】[0064]
【化9】 [Chemical 9]
【0065】[0065]
【表8】 [Table 8]
【0066】表8の結果から明らかなように、本発明品
を塗布することによりヘアレスマウス背部に生成したし
わを減少させることができた。As is clear from the results shown in Table 8, the wrinkles formed on the back of the hairless mouse could be reduced by applying the product of the present invention.
【0067】上記の実施例の結果から明らかなように特
定のアミン誘導体とアミド誘導体を併用配合した本発明
の皮膚外用剤は、皮膚老化防止効果(保湿及び肌荒れ予
防・改善、角質正常化、しわの予防・改善等)が相乗的
に高められたものであった。As is clear from the results of the above examples, the external preparation for skin of the present invention in which a specific amine derivative and an amide derivative are used in combination has a skin aging preventive effect (moisturizing and skin roughening prevention / improvement, keratin normalization, wrinkle normalization, wrinkles). Prevention, improvement, etc.) were synergistically enhanced.
【0068】実施例4 表9に示すサンスクリーンクリームを下記製法により調
製した。得られたサンスクリーンクリームは、皮膚老化
防止効果に優れるものであった。Example 4 The sunscreen cream shown in Table 9 was prepared by the following method. The obtained sunscreen cream was excellent in the effect of preventing skin aging.
【0069】[0069]
【表9】 (組成) (%) (1)アミン誘導体*7 0.1 (2)アミド誘導体*8 7.0 (3)シリコン被覆酸化亜鉛 7.0 (4)P−メトキシ桂皮酸2−エチルヘキシル 2.5 (5)ビタミンEアセテート 0.2 (6)コレステリルイソステアレート 2.0 (7)ポリエーテル変性シリコーン*9 3.0 (8)メチルポリシロキサン*10 6.0 (9)環状シリコーン*11 10.0 (10)硫酸マグネシウム 1.0 (11)グリセリン 5.0 (12)防腐剤 適量 (13)精製水 残量[Table 9] (Composition) (%) (1) Amine derivative * 7 0.1 (2) Amide derivative * 8 7.0 (3) Silicon-coated zinc oxide 7.0 (4) P-methoxycinnamic acid 2- Ethylhexyl 2.5 (5) Vitamin E acetate 0.2 (6) Cholesteryl isostearate 2.0 (7) Polyether-modified silicone * 9 3.0 (8) Methylpolysiloxane * 10 6.0 (9) Cyclic Silicone * 11 10.0 (10) Magnesium sulphate 1.0 (11) Glycerin 5.0 (12) Preservative proper amount (13) Purified water Remaining amount
【0070】*7:式(1)において、 R1=CH3−,R2=−CH2CH2OH,R3=R4=R5
=R6=H *8:式(2)において、 R7=C15H31,R8=−CH=CH(CH2)12CH3 ,
Y=H,Z=−CH2CH2OH,A=−O−CH2− *9:シリコーンKF−6015,信越化学工業(株)
製 *10:シリコーンKF−96A(6cs) ,信越化学工
業(株)製 *11:シリコーンSH−244、SH−245又はS
H−244とSH−245の3:2(重量比)混合物,
東レダウコーニング・シリコーン(株)製* 7: In the formula (1), R 1 = CH 3- , R 2 = -CH 2 CH 2 OH, R 3 = R 4 = R 5
= R 6 = H * 8: In the formula (2), R 7 = C 15 H 31, R 8 = -CH = CH (CH 2) 12 CH 3,
Y = H, Z = -CH 2 CH 2 OH, A = -O-CH 2 - * 9: Silicone KF-6015, Shin-Etsu Chemical Co.,
* 10: Silicone KF-96A (6cs), manufactured by Shin-Etsu Chemical Co., Ltd. * 11: Silicone SH-244, SH-245 or S
3: 2 (weight ratio) mixture of H-244 and SH-245,
Toray Dow Corning Silicone Co., Ltd.
【0071】(製法)(1)〜(8)を80℃に加温し
て溶解し、これに(10)〜(13)を加えて、均一に
混合し、50℃に攪拌冷却後(9)を均一に混合し、保
湿サンスクリーンクリームを調整した。(Manufacturing method) (1) to (8) were heated to 80 ° C. to dissolve them, (10) to (13) were added thereto, and they were mixed homogeneously and cooled to 50 ° C. with stirring (9). ) Was uniformly mixed to prepare a moisturizing sunscreen cream.
【0072】実施例5 表10に示す組成の油性ファンデーションクリームを下
記製法により調製した。得られた油性ファンデーション
クリームは、皮膚老化防止効果に優れたものであった。Example 5 An oily foundation cream having the composition shown in Table 10 was prepared by the following method. The obtained oily foundation cream was excellent in the effect of preventing skin aging.
【0073】[0073]
【表10】 (組成) (%) (1)アミン誘導体*12 0.05 (2)アミド誘導体*13 5.0 (3)シリコン被覆亜鉛 6.0 (4)P−メトキシ桂皮酸2−エチルヘキシル 3.0 (5)コレステリルイソステアレート 2.5 (6)ポリエーテル変性シリコール*14 3.0 (7)メチルポリシロキサン*15 4.0 (8)環状シリコーン*16 8.0 (9)スクワラン 2.0 (10)グリセリン 3.0 (11)酸化チタン 1.5 (12)カオリン 1.5 (13)ベンガラ 0.02 (14)黄酸化鉄 0.02 (15)防腐剤 適量 (16)香料 適量 (17)精製水 残量[Table 10] (Composition) (%) (1) Amine derivative * 12 0.05 (2) Amide derivative * 13 5.0 (3) Silicon-coated zinc 6.0 (4) 2-Ethylhexyl P-methoxycinnamate 3.0 (5) Cholesteryl isostearate 2.5 (6) Polyether-modified silicol * 14 3.0 (7) Methylpolysiloxane * 15 4.0 (8) Cyclic silicone * 16 8.0 (9) Squalane 2.0 (10) Glycerin 3.0 (11) Titanium oxide 1.5 (12) Kaolin 1.5 (13) Red iron oxide 0.02 (14) Yellow iron oxide 0.02 (15) Preservative proper amount (16) Perfume Suitable amount (17) Purified water Remaining amount
【0074】*12:式(1)において、 R1=CH3CH2−,R2=−CH2CH2OH,R3=R4
=R5=R6=H *13:式(2)において、 R7=C10H21,R8=−CH2(CH2)10CH3,Y=
H,Z=−CH2CH2CH2OH,A=−O−CH2− *14:シリコーンKF−6015,信越化学工業
(株)製 *15:シリコーンKF−96(10cs) ,信越化学工
業(株)製 *16:シリコーンSH−244、SH−245又はS
H−244とSH−245の3:2(重量比)混合物,
東レダウコーニング・シリコーン(株)製* 12: In the formula (1), R 1 = CH 3 CH 2- , R 2 = -CH 2 CH 2 OH, R 3 = R 4
= R 5 = R 6 = H * 13: In the formula (2), R 7 = C 10 H 21, R 8 = -CH 2 (CH 2) 10 CH 3, Y =
H, Z = -CH 2 CH 2 CH 2 OH, A = -O-CH 2 - * 14: Silicone KF-6015, Shin-Etsu Chemical Co., Ltd. * 15: Silicone KF-96 (10 cs), Shin-Etsu Chemical Co. * 16: Silicone SH-244, SH-245 or S
3: 2 (weight ratio) mixture of H-244 and SH-245,
Toray Dow Corning Silicone Co., Ltd.
【0075】(製法)油相成分(1)〜(7)、(9)
を80℃で加熱溶解したものに、攪拌しながら80℃に
加熱した水相成分(10)、(15)、(17)を加え
て乳化した後、50℃まで攪拌冷却後(8)、(11)
〜(14)、(16)を加え、更に攪拌しながら室温ま
で冷却して油性ファンデーションクリームを調製した。(Production method) Oil phase components (1) to (7), (9)
After heating and dissolving at 80 ° C, the aqueous phase components (10), (15), and (17) heated to 80 ° C with stirring were added to emulsify, and after stirring and cooling to 50 ° C, (8), ( 11)
(14) and (16) were added, and the mixture was further cooled to room temperature with stirring to prepare an oily foundation cream.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 31/16 AGZ 9455−4C ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location A61K 31/16 AGZ 9455-4C
Claims (1)
〜5のヘテロ原子を含有する炭化水素基を示し、R2、
R3、R4、R5及びR6は、同一又は異なって、水素原子
又は炭素数1〜20の水酸基が置換していてもよい炭化
水素基を示す)で表わされるアミン誘導体及びその酸付
加塩から選ばれる一種又は二種以上、 (B)次の一般式(2) 【化2】 〔式中、R7は炭素数10〜26の直鎖又は分岐鎖の飽
和又は不飽和の炭化水素基を示し、R8は炭素数9〜2
5の直鎖又は分岐鎖の飽和又は不飽和の炭化水素基を示
し、Y及びZはそれぞれ水素原子又は−(CH2)n−O
H(ここでnは1〜3の数を示す)を示し、Aは単結合
又は−O−CH2−(但し、酸素原子はR7と結合する)
を示す〕で表わされるアミド誘導体から選ばれる一種又
は二種以上を含有することを特徴とする皮膚外用剤。1. The following components (A) and (B): (A) The following general formula (1): (In the formula, R 1 is a hydrocarbon group having 1 to 3 carbon atoms or 1 carbon atom.
A hydrocarbon group containing a heteroatom of ~ 5, R 2 ,
R 3 , R 4 , R 5 and R 6 are the same or different and each represent a hydrogen atom or a hydrocarbon group which may be substituted with a hydroxyl group having 1 to 20 carbon atoms) and an acid addition thereof. One or more selected from salts, (B) the following general formula (2): [In the formula, R 7 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms, and R 8 represents 9 to 2 carbon atoms.
5 represents a linear or branched, saturated or unsaturated hydrocarbon group, Y and Z are each a hydrogen atom or a - (CH 2) n -O
H (where n is a number of 1 to 3) indicates, A represents a single bond or -O-CH 2 - (provided that the oxygen atom binds to R 7)
The external preparation for skin comprising one or more selected from amide derivatives represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17501294A JP3660374B2 (en) | 1994-07-27 | 1994-07-27 | Topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17501294A JP3660374B2 (en) | 1994-07-27 | 1994-07-27 | Topical skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0834720A true JPH0834720A (en) | 1996-02-06 |
JP3660374B2 JP3660374B2 (en) | 2005-06-15 |
Family
ID=15988679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP17501294A Expired - Fee Related JP3660374B2 (en) | 1994-07-27 | 1994-07-27 | Topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3660374B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013224291A (en) * | 2012-04-20 | 2013-10-31 | Rohm & Haas Co | Benzylamine hydrophobe |
JP2019112315A (en) * | 2017-12-21 | 2019-07-11 | ポーラ化成工業株式会社 | Compositions |
-
1994
- 1994-07-27 JP JP17501294A patent/JP3660374B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013224291A (en) * | 2012-04-20 | 2013-10-31 | Rohm & Haas Co | Benzylamine hydrophobe |
US9156776B2 (en) | 2012-04-20 | 2015-10-13 | Rohm And Haas Company | Benzylamine hydrophobe |
JP2019112315A (en) * | 2017-12-21 | 2019-07-11 | ポーラ化成工業株式会社 | Compositions |
Also Published As
Publication number | Publication date |
---|---|
JP3660374B2 (en) | 2005-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU697389B2 (en) | Skin-conditioning composition its application and manufacture | |
JP4729343B2 (en) | Use of a composition comprising at least one chelating agent for increasing the tolerance limit of sensitive or intolerant skin | |
JP2024026372A (en) | Skin condition improving agents | |
JPH0657651B2 (en) | Cosmetic composition | |
CA2365660A1 (en) | Treatment for skin | |
JP3908953B2 (en) | Skin preparations and drugs | |
JP5455292B2 (en) | Skin external composition | |
JPH11269042A (en) | Cosmetic for scalp and hair | |
JPH11269043A (en) | Cosmetic for scalp and hair | |
JPH09175983A (en) | Skin preparation for external use | |
JP3660374B2 (en) | Topical skin preparation | |
JPH082772B2 (en) | Sebum secretagogue | |
JP3220275B2 (en) | Wrinkle improver | |
JP2699132B2 (en) | Keratinizing agent and external preparation for skin containing same | |
JP2741143B2 (en) | External preparation for skin | |
JPS617205A (en) | Cell activator | |
JP2002212045A (en) | Skin care preparation for ameliorating and preventing nonallergic chapped skin and skin care preparation for ameliorating and preventing pimple | |
JP2003183148A (en) | Skin care composition for external use | |
JPS617206A (en) | Cell activator | |
JP2002121108A (en) | Skin care preparation for ameliorating chapped skin | |
JP3512890B2 (en) | External preparation for preventing skin aging | |
JPH10226617A (en) | Skin preparation for external use | |
JP3215534B2 (en) | External preparation for skin | |
JP3160415B2 (en) | Wrinkle improver and keratosis improver | |
JPH0853334A (en) | Dermal agent for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A61 | First payment of annual fees (during grant procedure) |
Effective date: 20050317 Free format text: JAPANESE INTERMEDIATE CODE: A61 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080325 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 4 Free format text: PAYMENT UNTIL: 20090325 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 4 Free format text: PAYMENT UNTIL: 20090325 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100325 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100325 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110325 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20110325 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 7 Free format text: PAYMENT UNTIL: 20120325 |
|
LAPS | Cancellation because of no payment of annual fees |